Most read article(s)

Research Article
Immune Response and Safety of SARS-CoV-2 mRNA-1273 Vaccine in Patients With Myasthenia Gravis
David Reyes-Leiva, Joaquín López-Contreras, Esther Moga, et al.

June 21, 2022
Article
Rituximab Treatment and Long-term Outcome of Patients With Autoimmune EncephalitisReal-world Evidence From the GENERATE Registry
Franziska S. Thaler, Luise Zimmermann, Stefan Kammermeier, et al.

October 01, 2021
Article
Rituximab before and during pregnancyA systematic review, and a case series in MS and NMOSD
Gitanjali Das, Vincent Damotte, Jeffrey M. Gelfand, et al.

March 19, 2018
Research Article
Rituximab-Induced Hypogammaglobulinemia and Risk of Infection in Neuromyelitis Optica Spectrum DisordersA 14-Year Real-Life Experience
Su-Hyun Kim, Na Young Park, Ki Hoon Kim, et al.

July 19, 2022
Article
Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic diseaseMore to come with myositis in the offing
Marinos C. Dalakas

June 09, 2020
Article
International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis
Margherita Nosadini, Terrence Thomas, Michael Eyre, et al.

July 22, 2021
Research Article
IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
Alexandre Jentzer, Arthur Attal, Clémence Roué, et al.

August 10, 2022
Article
Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody
Keisuke Yoshikawa, Motoi Kuwahara, Miyuki Morikawa, et al.

September 15, 2020
Research Article
Long-term Effectiveness of IVIg Maintenance Therapy in 36 Patients With GAD Antibody–Positive Stiff-Person Syndrome
Jessica Yi, Marinos C. Dalakas

July 07, 2022
Research Article
Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
Michael J. Peluso, Hannah M. Sans, Carrie A. Forman, et al.

June 14, 2022

Pages